F17464 in Acute Schizophrenia Trial
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 142
Summary
- Conditions
- Schizophrenia
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 64 years
- Gender
- Both males and females
Tracking Information
- NCT #
- NCT02151656
- Collaborators
- Not Provided
- Investigators
- Study Director: Françoise TONNER, MD Pierre Fabre Medicament
Get Well Soon